Author: Janine Anthes

Insurers are expanding their participation in the program

Heroin, fentanyl, and other opioids continue to be the highest drug threat in the nation

Dsuvia use restricted to operating rooms or on the battlefield

Here are what the editors at HealthDay consider to be the most important developments in Allergy for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Oral Immunotherapy Beneficial in Patients With Wheat Allergy […]

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Some Weather Conditions Linked to Myocardial Infarction Risk […]

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician Training TUESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Link Between Statins, Non-CVD Outcomes Lacks […]

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Opioid Use Often Persists in Workers’ Compensation […]

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Greater Weight Loss With Gastric Bypass Than Other […]

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician […]

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Antibiotics, Acid Suppressants in Infancy May Up […]

Here are what the editors at HealthDay consider to be the most important developments in Neurology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Link Between Statins, Non-CVD Outcomes Lacks Evidence WEDNESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Nursing for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Opioid Use Often Persists in Workers’ Compensation Claimants […]

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Black, Low-Income Women May Not […]

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Barriers to Prostate Cancer Research in […]

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician Training TUESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician Training TUESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. 50 Percent of Children Aged 2 to 5 […]

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Opioid Use Often Persists in Workers’ Compensation Claimants […]